Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 8/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP7 | P09237 | 1/20 | 0.52 |
| ▸ | MMP14 | P50281 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24106342 | 0.83 | MAPT (0.53) | HSD11B1MMP2MMP7MMP14POLB | |
| Hydrochloric Acid SCHEMBL30116899 | 0.83 | HSD11B1 (0.51) | HSD11B1MMP2MMP7MMP14POLB | |
| SCHEMBL8572063 | 0.83 | ALDH1A1 (0.61) | HSD11B1POLBKMT2AALDH1A1TP53 | |
| SCHEMBL3182773 | 0.80 | HSD11B1 (0.53) | HSD11B1MMP2MMP7MMP14POLB | |
| SCHEMBL194095 | 0.80 | HSD11B1 (0.53) | HSD11B1MMP2MMP7MMP14POLB | |
| SCHEMBL6795476 | 0.80 | PRMT1 (0.61) | POLBKMT2ASMN1; SMN2HTTCA12 | |
| SCHEMBL6789657 | 0.79 | NPC1 (0.56) | HSD11B1MMP2MMP7MMP14ALDH1A1 | |
| SCHEMBL7210507 | 0.79 | HTT (0.58) | HSD11B1POLBKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL270706 | 0.79 | MMP2 (0.77) | HSD11B1MMP2MMP7MMP14POLB | |
| SCHEMBL5080063 | 0.78 | HSD11B1 (0.58) | HSD11B1POLBKMT2AALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109776324-A | Homoallyltrifluoromethyl compound and preparation method thereof | 南京工业大学 | 2019-05-21 | — | — | CN | claimed |
| US-12435027-B1 | Preparation method of N-butenyl amide compounds | ZHEJIANG NORMAL UNIVERSITY (CN) | 2025-10-07 | — | — | US | disclosed |
| CN-109776324-A | Homoallyltrifluoromethyl compound and preparation method thereof | 南京工业大学 | 2019-05-21 | — | — | CN | disclosed |
| US-7306893-B2 | Intermediate layer contains a unsaturated polymer having a carboxylic acid group in the side chain, which has specific reaction between the support and the photosensitive layer to promot adhesion strength; improve printing durability, chemical resistance; laser recording, photothermography | FUJIFILM CORPORATION (JP) | 2007-12-11 | — | — | US | disclosed |
| US-20050048399-A1 | Intermediate layer contains a unsaturated polymer having a carboxylic acid group in the side chain, which has specific reaction between the support and the photosensitive layer to promot adhesion strength; improve printing durability, chemical resistance; laser recording, photothermography | FUJI PHOTO FILM CO., LTD. | 2005-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435027-B1 | Preparation method of N-butenyl amide compounds | BBOX1, NAT1, AADAC | HSD11B1 3155/4885MMP2 3931/4885MMP7 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.